Skip Navigation



Glycobiology Advance Access published online on April 6, 2005
Glycobiology, doi:10.1093/glycob/cwi059
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
15/8/791    most recent
cwi059v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Thomsson, K. A.
Right arrow Articles by Karlsson, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomsson, K. A.
Right arrow Articles by Karlsson, N. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oupjournals.org
Received November 9, 2004
Accepted March 28, 2005

Article

MUC5B Glycosylation in Human Saliva Reflects Blood Group and Secretor Status

Kristina A. Thomsson 1, Benjamin L. Schulz 2, Nicolle H. Packer 2, and Niclas G. Karlsson 2*

1 Department of Medical Biochemistry, Göteborg University, Box 440, 405 30 Göteborg, Sweden
2 Proteome Systems Limited, Locked Bag 2073, North Ryde, Sydney, NSW 1670, Australia

* To whom correspondence should be addressed.
Niclas G. Karlsson, E-mail: Niclas.Karlsson{at}proteomesystems.com


  Abstract

This study aimed to characterize human salivary glycoforms and the natural glycosylation variation of the major ABO blood group bearing high-molecular-weight glycoprotein fraction MG1, which mainly consists of MUC5B mucin. Reduced and alkylated mucins from individuals of blood group A, B and O were purified by sodium dodecyl sulfate-agarose/polyacrylamide composite gel electrophoresis, blotted to PVDF membranes and visualised with Alcian Blue. O-linked oligosaccharides were released from MUC5B glycoform bands by reductive {beta}-elimination and analysed by liquid chromatography electrospray ion trap mass spectrometry. Slow electrophoretically migrating MUC5B components were found to be dominated by neutral oligosaccharides, and fast migrating components were dominated by sulfated oligosaccharides. ABO blood group specific sequences were found on all glycoforms and novel oligosaccharides containing blood group A and B type sequences were sequenced. This is the first molecular description of the influence of the blood group ABO system on salivary MUC5B oligosaccharides. Expanding these results from the three A, B and O individuals into larger population (29 individuals), we found oligosaccharide sequences corresponding to the blood group of the donor on MUC5B from 23 individuals. The remaining six individuals were characterised by a high degree of sialylation. These individuals were assigned as non-secretors, while blood group expressing individuals were assigned as secretors. Western blot assays with antibodies confirmed increased expression of Si-Lea in the non-secretors. Our results highlight that salivary MUC5B consists of glycoforms with distinct glycosylation that varies extensively between individuals, and that some of this variation is due to blood group and secretor status.

Keywords: glycoforms/mass spectrometry/MUC5B/saliva.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol. Cell. ProteomicsHome page
Y. Andersch-Bjorkman, K. A. Thomsson, J. M. Holmen Larsson, E. Ekerhovd, and G. C. Hansson
Large Scale Identification of Proteins, Mucins, and Their O-Glycosylation in the Endocervical Mucus during the Menstrual Cycle
Mol. Cell. Proteomics, April 1, 2007; 6(4): 708 - 716.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.